Mode
Text Size
Log in / Sign up
N/A Completed N=118 Randomized Single-blind Treatment

Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses

Source: ClinicalTrials.gov NCT01155323 ↗
Enrolled (actual)
118
Serious AEs
0.0%
Results posted
Oct 2011
Primary outcomePrimary: Subjective Rating of Comfort — 3.33; 3.32 Units on a scale

Summary

This study seeks to evaluate and compare the clinical performance of two daily disposable soft contact lenses, Proclear 1 Day and 1-Day Acuvue Moist.

Outcome Measures

OutcomeResultp-value
PRIMARY
Subjective Rating of Comfort
3.33; 3.32 —
PRIMARY
Vision Quality
3.53; 3.50 —
PRIMARY
Subjective Rating of Handling
3.48; 3.48 —
PRIMARY
Corneal Staining
0.07; 0.09 —
PRIMARY
Subjective Rating of Quality Perceptions
3.51; 3.44 —
PRIMARY
Limbal Hyperemia
0.51; 0.48 —

Eligibility Criteria

Inclusion Criteria

  • At least 18 years of age and no more than 39 years of age
  • Existing soft contact lens wearers
  • Willing to signed a written Informed Consent.
  • Own a mobile phone and are willing to receive and reply to Short Message Service (SMS) messages during the day.
  • Have a contact lens spherical distance requirement between -1.00 diopters (D) and -6.00 diopters (D) in both eyes.
  • Have an Astigmatism of 1.00D or less in both eyes.
  • Require a visual correction in both eyes.
  • Be correctable to a visual acuity of 6/9 (20/30) or better in each eye.
  • Have normal eyes with no evidence of abnormality or disease that would preclude lens wear.

Exclusion Criteria

  • Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, tarsal abnormalities, bulbar infection, or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Clinically significant corneal staining (Grade 3 in more than one region).
  • Keratoconus or other corneal irregularity.
  • Abnormal lachrymal secretions.
  • Extended wear of contact lenses last 3 months.
  • Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in the previous 8 weeks.
  • Refractive surgery.
  • Eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Require concurrent ocular medication
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Any infectious disease (e.g., hepatitis, tuberculosis) or any immunosuppressive disease (e.g., HIV).
  • Diabetes.
  • Pregnant, lactating or planning a pregnancy at the time of enrollment.
  • Participation in any concurrent clinical trial or in last 30 days.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01155323). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search